Artal Group S.A. 13F Holdings · Q2 2026
Artal Group S.A. reported 2 securities worth $931.12M in its SEC 13F filing for Q2 2026 (period ended 2026-06-30). Top holdings: CAVA (54.85%), LXRX (45.15%). Among its top 25 positions this quarter: 1 added, 1 trimmed.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | CAVA | Cava Group Inc | $510.7M | 54.85% | 6.5M | Trimmed |
| 2 | LXRX | Lexicon Pharmaceuticals Inc | $420.4M | 45.15% | 175.2M | Added |
Source: SEC Form 13F filings · as of 2026-06-30
Every position in this 13F-HR, with its change from the prior quarter.
13F holdings, latest quarter
SourceSEC EDGAR13F-HR